Universal Vision Biotechnology Co (ROCO:3218) COGS-to-Revenue : 0.42 (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Universal Vision Biotechnology Co COGS-to-Revenue?

Universal Vision Biotechnology Co's Cost of Goods Sold for the three months ended in Dec. 2023 was NT$415 Mil. Its Revenue for the three months ended in Dec. 2023 was NT$993 Mil.

Universal Vision Biotechnology Co's COGS to Revenue for the three months ended in Dec. 2023 was 0.42.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Universal Vision Biotechnology Co's Gross Margin % for the three months ended in Dec. 2023 was 58.17%.

Universal Vision Biotechnology Co COGS-to-Revenue Historical Data

The historical data trend for Universal Vision Biotechnology Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Vision Biotechnology Co COGS-to-Revenue Chart

Universal Vision Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.42

0.38

0.39

0.40

Universal Vision Biotechnology Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.38	0.39	0.39	0.41	0.42

Universal Vision Biotechnology Co COGS-to-Revenue Calculation

Universal Vision Biotechnology Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1633.886	/	4082.256
	=	0.40

Universal Vision Biotechnology Co's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	415.274	/	992.876
	=	0.42

Universal Vision Biotechnology Co (ROCO:3218) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Universal Vision Biotechnology Co's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	415.274 / 992.876
	=	58.17 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Universal Vision Biotechnology Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Universal Vision Biotechnology Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Vision Biotechnology Co (ROCO:3218) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Universal Vision Biotechnology Co Ltd (ROCO:3218) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3-1, Yuanyuan Street, 4th Floor, Nangang District, Taipei, TWN, 115

Website

https://www.uvb.com.tw

Universal Vision Biotechnology Co Ltd provides eye treatment and related medical services in Taiwan. It also provides optical devices, glasses, lens and other vision aid products, optometric services, sales and leasing of medical devices, providing of hospital management and technical consultancy services.

Universal Vision Biotechnology Co (ROCO:3218) Headlines

No Headlines